vosaroxin sns voreloxin topoisomerase ii inhibitor causing siteselective dna damage phase iii clinical trial investigation acute myelogenous leukemia aml ovarian cancer sponsored vosaroxin naphthyridine analog anticancer quinolone derivatives aqds class compounds used previously treatment cancer topoisomerase ii enzymes essential survival eukaryotic cells vosaroxin hinders reunion topoisomerase iiinduced doublestrand breaks selective sites dna resulting arrest cell death antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikivosaroxin